DOCSLIB.ORG

Desktop Access to Elsevier's Sciencedirect Journals, Ebooks And

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Desktop Access to Elsevier's Sciencedirect Journals, Ebooks And Desktop access to Elsevier’s ScienceDirect journals, eBooks and Scopus citation database (Jan. – Dec. 2020) Elsevier and Life Science Intelligence at NCBiotech are partnering to offer eligible companies special rates on subscriptions to scientific literature and other products. Ensure that your team has the information it needs, at rates your company can afford. For the purpose of this agreement, the term “researcher” is defined as any scientist, biologist, biochemist, chemist, clinician, physician, etc. employed by participating companies and actively engaged in research and development. ScienceDirect Journals Whether you’re a scientist, researcher, chemist or engineer, driving innovation and supporting R&D and product development can be a challenge—especially while balancing commercial demands. ScienceDirect helps you make quicker, more confident decisions by giving you instant access to the latest scholarly developments. ScienceDirect combines authoritative, highly-cited full-text scientific, technical and health publications with smart, intuitive functionality so that your team can stay informed and work more effectively. ScienceDirect hosts over 3,800 journals and more than 39,000 books—over 15 million peer-reviewed publications. Subscription Pricing • $5,205 minimum for three licenses • $1,735 for each additional researcher license List price is over $50,000 per company for a minimum of 50 researchers Learn more: elsevier.com/solutions/sciencedirect ScienceDirect Corporate Edition for Books Sometimes researchers need book resources in addition to journal articles. To meet this need, Elsevier has compiled over 14,000 electronic books into this collection, spanning all scientific and medical disciplines. The collection includes book series, reference works, handbooks and other books, back to 1995. Subscription Pricing • $5,000 minimum for 20 researchers • $250 for each additional research license List price is $12,201 for 1-50 researchers Cell Press Journals With a commitment to improving scientific communication, Cell Press publishes leading primary research and review journals covering the full and exciting spectrum of biology. Each company that subscribes to ScienceDirect through the NCBiotech program may also subscribe to Cell Press journals at a reduced rate. Add-on Subscription Pricing • Up to 2 Cell Press Journals: 5% off the combined subscription cost • 3 to 4 Cell Press Journals: 10% off the combined subscription cost • 5 to 7 Cell Press Journals: 15% off the combined subscription cost • 8 or more Cell Press Journals: 20% off the combined subscription cost Learn more: elsevier.com/books-and-journals/cell-press Scopus Citation Database Scopus, the largest curated abstract and citation Scopus content coverage by database of peer-reviewed literature, features smart subject area tools to track, analyze and visualize research. Updated daily and including over 71 million records indexed from journals, books and conference papers, Scopus Life delivers the most comprehensive overview of the Sciences 16% world’s research output in the fields of science, Health technology, medicine, social sciences and arts and Sciences humanities. 31% Subscription Pricing Social Sciences • $7,600 minimum for ten licenses 25% • $760 for each additional researcher license List price is $24,380 for 1-25 researchers Physical Sciences Learn more: elsevier.com/solutions/scopus 28% Contact To begin a subscription to one or a combination of products, or add a new product to your subscriptions, contact either the Elsevier or NCBiotech representative. Companies will sign an MOU with NCBiotech, but license agreements, payments and renewals will be handled through Elsevier. Patrick Lundy Lori Melliere Elsevier Account Representative Outreach & Client Services Librarian, NCBiotech (908) 432-1881 (919) 549-8855 [email protected] [email protected] .
Load more

Recommended publications
  • Sciencedirect Empowering Researchers at Every Step
    ScienceDirect Empowering researchers at every step Training ScienceDirect for Institut Teknologi Bandung By Ujang Sanusi Customer Consultant ELSEVIER INDONESIA | 2 Elsevier is a world-leading Science, Health & Technology Information Provider CONTENT PROVISION ‘E’ CONTENT PROVISION RESEARCH MGMT SEARCH & DISCOVERY /PROMOTION TOOLS Niels Louis Alexander Albert George F. John C. Roger D. Craig C Mello Bohr Physics Pasteur Fleming Einstein Smoot Mather Kornberg Medicine (Chemistry) Medicine Physics Physics Physics Chemistry 2 | 3 Elsevier is engaging across the research workflow ScienceDirect – Extensive Multi-disciplinary Full-Text Database ScienceDirect is the largest online journal platform in the world with more than 2,500 journals in 24 subject areas owned and published by Elsevier and more than 33,000 eBooks. • Publishes over 25% of the world’s full-text scientific journals with several high- profile journal titles such as Cell, The Lancet and Tetrahedron • Over 13,859,000 articles are available online • It is also the most referenced journal platform in the world with an average of 25% citations coming from journals on ScienceDirect • Over 250,000 articles on ScienceDirect are open access Elsevier is the top scientific content provider of vital interdisciplinary information essential across industries and disciplines Scientific Research Articles Published Multi-disciplinary content Env Earth SciencesSciences #1 Global Provider ELS Life Sciences* 25% Soc Sciences Publish 25% of world’s journal articles Math & 2,500 active journals Comp
    [Show full text]
  • Tissue and Cell
    TISSUE AND CELL AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.3 ISSN: 0040-8166 DESCRIPTION . Tissue and Cell is devoted to original research on the organization of cells, subcellular and extracellular components at all levels, including the grouping and interrelations of cells in tissues and organs. The journal encourages submission of ultrastructural studies that provide novel insights into structure, function and physiology of cells and tissues, in health and disease. Bioengineering and stem cells studies focused on the description of morphological and/or histological data are also welcomed. Studies investigating the effect of compounds and/or substances on structure of cells and tissues are generally outside the scope of this journal. For consideration, studies should contain a clear rationale on the use of (a) given substance(s), have a compelling morphological and structural focus and present novel incremental findings from previous literature. IMPACT FACTOR . 2020: 2.466 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . Scopus PubMed/Medline Cambridge Scientific Abstracts Current Awareness in Biological Sciences Current Contents - Life Sciences Embase Embase Science Citation Index Web of Science EDITORIAL BOARD . Editor Pietro Lupetti, University of Siena, Siena, Italy AUTHOR INFORMATION PACK 1 Oct 2021 www.elsevier.com/locate/tice 1 Managing Editor Giacomo Spinsanti, University of Siena,
    [Show full text]
  • Announcement
    Announcement Total 100 articles, created at 2016-06-09 18:04 1 Best mobile games of 2016 (pictures) Looking for a new game to play on your mobile device? Here's our pick of the best released in 2016 (so far). 2016-06-09 12:53 677Bytes (1.08/2) www.cnet.com 2 Apple revamps App Store, may not win over developers Apple Inc. announced a series of long-awaited enhancements to (1.05/2) its App Store on Wednesday, but the new features may not ease concerns of developers and analysts who say that the App Store model - and the very idea of the single-purpose app - has... 2016-06-09 08:46 4KB pctechmag.com 3 HPE Unveils Converged Systems for IoT The Edgeline EL1000 and EL4000 systems are part of a larger series of announcements by HPE to address such IoT issues as (1.02/2) security and management. 2016-06-09 12:49 5KB www.eweek.com 4 What is AmazonFresh? Amazon launches new grocery service for the UK: Can I get (1.02/2) AmazonFresh in the UK? What is AmazonFresh, Amazon launches new grocery service for the UK, Can I get AmazonFresh in the UK, where does AmazonFresh deliver, what does AmazonFresh deliver 2016-06-09 12:42 3KB www.pcadvisor.co.uk 5 Borderlands 3 UK release date, price and gamelplay rumours: Gearbox has confirmed the (1.02/2) game is being developed Gearbox, the developers behind the Borderlands series are back it again with a new game on the horizon. 2016-06-09 11:00 3KB www.pcadvisor.co.uk 6 More Than 32 Million Twitter Passwords May Have Been Hacked And Leaked On The Dark (1.02/2) Web Last week Facebook’s CEO Mark Zuckerberg's social accounts; Pinterest and Twitter were briefly hacked, with the details coming from the LinkedIn breach that happened in 2012, with the founder of the world’s biggest social network reusing the password “dadada.” This time around Twitter users have become the..
    [Show full text]
  • 2017 Elsevier Foundation Annual Report
    2017 Elsevier Foundation Report Médecins Sans Frontiers doctors conduct a Phase III rotavirus vaccine trial at Epicentre’s Niger Research Center at the Maradi Hospital, which receives an annual capacity building grant of $100,000 from the Elsevier Foundation. © KRISHAN Cheyenne/MSF White City students at a recent Imperial College London workshop with the student drone society. The Elsevier Foundation supported Maker’s Challenge space will launch in September, hosting future White City students as they navigate 3D printers, tackle robotics and many other tech challenges. © Imperial College London 2017 OWSD-Elsevier Foundation woman scientist award winner Felycia Edi Soetaredjo, PhD, Lecturer at Widya Mandala Surabaya Catholic University in Surabaya, Indonesia, was recognized for her work utilizing waste and cheap materials for environmental remediation of renewable energy. © Widya Mandala Surabaya Catholic University The Elsevier Foundation 2017 Board Report 2 Contents Foreword: Youngsuk “YS” Chi, President of the Elsevier Foundation I. The Elsevier Foundation 1. Who we are 2. Our Board 3. Our Programs 4. Our Future II. Our Programs 1. Health & Innovation 2. Research in Developing Countries 3. Diversity in STM 4. Technology for Development IV. Matching Gift V. Media Outreach VI. Financial Overview VII. Appendix The Elsevier Foundation 2017 Board Report 3 The Elsevier Foundation 2017 Board Report 4 Foreword On the occasion of the September 2017 Elsevier Foundation Board Meeting It has been an incredible privilege to steer collaboration in Sustainability. The TWAS the Elsevier Foundation’s development Elsevier Foundation Program provides over the last decade. I continue to be travel grants for PhD’s and postdoc inspired by the dedication and resolve of scientists studying in sustainability fields this group as we strive to tackle important and hosts case study competitions to global challenges.
    [Show full text]
  • The Rewards of Platform Unity: Moving to One Repository at Universidad De La Salle Delivers Benefits
    Case Study The rewards of platform unity: moving to one repository at Universidad de La Salle delivers benefits To better support the mission that drives Colombia’s Universidad de La Salle — to generate knowledge that will transform Colombian society by contributing to equity, the defense of life and human development — the university recognized the need to combine three separate digital platforms into a single unifying online presence while simultaneously addressing a long list of technical challenges. After considering several options, it identified Digital Commons as the perfect fit for its needs. This case study charts the university’s decision-making process, the rewards it has subsequently reaped and eight tips for other institutions embarking on a digital repository journey. Introduction Founded in 1964, Universidad de La Salle1 is a private Catholic the other its digital educative resources. So, a cross-department institution with around 14,000 students and 700 postgraduates task force set out to find a single solution that would provide enrolled in a wide array of courses and degree programs. It them with key items on their wish list: is rated a “High Quality University” by Colombia’s National Accreditation Council2 (CNA). Back in 2018, the institution’s five • One entry point to the university’s intellectual output journals were stored on Public Knowledge Project’s Open Journal • Support for the full journal-publishing cycle Systems (OJS) platform. Initially, OJS ticked many boxes for the (including peer review) journals team, as Editorial Head Alfredo Morales recalls: “We • Robust customer support were able to consolidate all our titles, standardize publishing criteria and increase visibility inside and outside the university.” • Effective SEO and indexing of journal articles in Google Scholar • Standardization of metadata But the team also encountered issues that impacted their productivity and content discoverability.
    [Show full text]
  • Using Open Access Literature to Guide Full-Text Query Formulation Heather A
    Using open access literature to guide full-text query formulation Heather A. Piwowar and Wendy W. Chapman Background Much scientific knowledge is contained in the details of the full-text biomedical literature. Most research in automated retrieval presupposes that the target literature can be downloaded and preprocessed prior to query. Unfortunately, this is not a practical or maintainable option for most users due to licensing restrictions, website terms of use, and sheer volume. Scientific article full-text is increasingly queriable through portals such as PubMed Central, Highwire Press, Scirus, and Google Scholar. However, because these portals only support very basic Boolean queries and full text is so expressive, formulating an effective query is a difficult task for users. We propose improving the formulation of full-text queries by using the open access literature as a proxy for the literature to be searched. We evaluated the feasibility of this approach by building a high-precision query for identifying studies that perform gene expression microarray experiments. Methodology and Results We built decision rules from unigram and bigram features of the open access literature. Minor syntax modifications were needed to translate the decision rules into the query languages of PubMed Central, Highwire Press, and Google Scholar. We mapped all retrieval results to PubMed identifiers and considered our query results as the union of retrieved articles across all portals. Compared to our reference standard, the derived full- text query found 56% (95% confidence interval, 52% to 61%) of intended studies, and 90% (86% to 93%) of studies identified by the full-text search met the reference standard criteria.
    [Show full text]
  • Since January 2020 Elsevier Has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID- 19
    Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. Available online at www.sciencedirect.com ScienceDirect Editorial overview: Membrane traffic in the time of COVID-19 Frances M. Brodsky and Jennifer L. Stow Current Opinion in Cell Biology 2020, 65:iii–v This overview comes from a themed issue on Membrane Trafficking Edited by Frances M. Brodsky and Jennifer L. Stow https://doi.org/10.1016/j.ceb.2020.09.003 0955-0674/© 2020 Published by Elsevier Ltd. Frances M. Brodsky We write this editorial emerging from lockdown in countries across the Division of Biosciences, University College world in the face of the COVID-19 pandemic. These have been chal- London, Gower Street, London, WC1E 6BT, lenging, frightening, and too often catastrophic times for many. Such times UK lead to evaluation of one’s own enterprise in the context of a global *Corresponding author: Brodsky, Frances M.
    [Show full text]
  • Get Noticed Promoting Your Article for Maximum Impact Get Noticed 2 GET NOTICED
    Get Noticed Promoting your article for maximum impact GET NOTICED 2 GET NOTICED More than one million scientific articles are published each year, and that number is rising. So it’s increasingly important for you to find ways to make your article stand out. While there is much that publishers and editors can do to help, as the paper’s author you are often best placed to explain why your findings are so important or novel. This brochure shows you what Elsevier does and what you can do yourself to ensure that your article gets the attention it deserves. GET NOTICED 3 1 PREPARING YOUR ARTICLE SEO Optimizing your article for search engines – Search Engine Optimization (SEO) – helps to ensure it appears higher in the results returned by search engines such as Google and Google Scholar, Elsevier’s Scirus, IEEE Xplore, Pubmed, and SciPlore.org. This helps you attract more readers, gain higher visibility in the academic community and potentially increase citations. Below are a few SEO guidelines: • Use keywords, especially in the title and abstract. • Add captions with keywords to all photographs, images, graphs and tables. • Add titles or subheadings (with keywords) to the different sections of your article. For more detailed information on how to use SEO, see our guideline: elsevier.com/earlycareer/guides GIVE your researcH THE IMpact it deserVes Thanks to advances in technology, there are many ways to move beyond publishing a flat PDF article and achieve greater impact. You can take advantage of the technologies available on ScienceDirect – Elsevier’s full-text article database – to enhance your article’s value for readers.
    [Show full text]
  • Inhibitors of Target Workflow
    Inhibitors of Target Which Substances are Potent and Selective Inhibitors of Target? Potent and Selective COX-2 It is clear that COX-2 plays an important role in tumor and endothelial cell biology. Increased expression of COX-2 occurs in multiple cells within the tumor microenvironment that can impact on angiogenesis. COX-2 appears to: Play a key role in the release and activity of proangiogenic proteins; Result in the production of eicosanoid products TXA2, PGI2, PGE2 that directly stimulate endothelial cell migration and angiogenesis in vivo, and Result in enhanced tumor cell, and possibly, vascular endothelial cell survival by upregulation of the antiapoptotic proteins Bcl-2 and/or activation of PI3K-Akt. Selective pharmacologic inhibition of COX-2 represents a viable therapeutic option for the treatment of malignancies. Agents that selectively inhibit COX-2 demonstrate that chronic treatment for angiogenesis inhibition is feasible. As a continuous research for discovery of new COX-2 inhibitors, new synthetic potent and selective inhibitors of COX-2 are of great interest as antiangiogenic agent. Let’s search for potent and selective inhibitors of Cyclooxygenase 2 (COX-2) versus Cyclooxygenase COX-1. Define the Search Query using the Query builder 1. On the Reaxys home page, click Query builder Copyright 2017 Elsevier B.V. Reaxys, RELX Group and the RE symbol are trade marks of RELX Intellectual Properties SA, used under license. 1 Inhibitors of Target 2. In the Find search fields and forms box, type selectivity The list if filtered to include fields and forms that include the word selectivity. In this case the Selectivity Profile form is displayed.
    [Show full text]
  • Sciencedirect ® Sciencedirect Books: High Impact, Relevant Content
    ScienceDirect ® ScienceDirect Books: High impact, relevant content These days, a world of information is at our fingertips. Simple online searches return millions of pages that claim to provide expert, timely information. But we’ve all had the experience of wondering if the information is trustworthy, accurate and the best to address our needs. Even casual web searchers are left wondering how to decipher the irrelevant information that fills online search result pages, so what’s a serious researcher to do in a world of overwhelming content and underwhelming relevancy? Elsevier offers greater clarity and insights for researchers by putting their needs first. ScienceDirect: A maximum impact, trusted research solution that delivers ScienceDirect, Elsevier’s leading online full-text information solution, is more than just a research destination for scientists; it’s a continuously evolving, dynamic repository that is constantly updated with the very latest research data available on a variety of subjects. Using the latest technology, the platform provides users with the answers they need, when they need them across a broad range of topics in science, technology and health, helping users attain a greater depth of information than other research solutions provide. Our data driven approach A user focused perspective based on the workflow and understanding the needs of researchers to build our publishing strategy Elsevier offers greater clarity and insights for researchers decisions. By providing data and analysis of their by putting their needs first. A wide range of relevant institution’s usage behavior on ScienceDirect to identify content combined with cutting-edge technology on the content gaps, a clear picture of in-demand content ScienceDirect platform provides quick, easily accessible emerges.
    [Show full text]
  • Information for Authors
    Information for Authors The Lancet is an international general medical journal that will consider any original contribution that advances or illuminates medical science or practice, or that educates or entertains the journal’s readers. Whatever you have written, remember that it is the general reader whom you are trying to reach. One way to find out if you have succeeded is to show your draft to colleagues in other specialties. If they do not understand, neither, very probably, will The Lancet’s staff or readers. Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. For randomised controlled trials or research papers judged to warrant fast dissemination, The Lancet will publish a peer-reviewed manuscript within 4 weeks of receipt (see Swift+ and Fast-track publication). If you wish to discuss your proposed fast-track submission with an editor, please call one of the editorial offices in London (+44 [0] 20 7424 4950), New York (+1 212 633 3667), or Beijing (+86 10 852 08872). The Lancet is a signatory journal to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Recommendations for the Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and to the Committee Conduct, Reporting, Editing, on Publication Ethics (COPE) code of conduct for editors. We follow COPE’s guidelines. and Publication of Scholarly Work in Medical Journals http://www.icmje.org If your question is not addressed on these pages then the journal’s editorial staff in London (+44 [0] 20 7424 4950), New York (+1 212 633 3810), or Beijing (+86 10 852 08872) will be pleased to help (email [email protected]).
    [Show full text]
  • Sciencedirect's Advanced Recommender a Fruitful Academic—Industrial Partnership
    ScienceDirect's Advanced Recommender a Fruitful Academic—Industrial Partnership Martin Rajman Craig Scott EPFL Elsevier [email protected] [email protected] 1 Academic-Industrial partnership Martin Rajman • Executive Director of Nano-Tera.ch, a large Swiss Research Program funding collaborative multi- disciplinary projects for the engineering of complex systems in Health and the Environment. • Senior researcher at EPF Lausanne, Switzerland (EPFL). His research interests include Artificial Intelligence, Computational Linguistics and Data- driven Probabilistic Machine Learning. • Active in various large scale industry-research collaborations with majors economic players. EPFL • EPFL is one of the two Swiss Federal Institutes of Technology and is located in Lausanne, Switzerland. It is considered to be among the worlds most prestigious universities in technology. 2 Academic-Industrial partnership Craig Scott • Senior Product Manager, Academic & Government Research Markets (ScienceDirect, Scopus, Scirus) • Amsterdam, Netherlands • Working on ‘big data’ experiments, A/B testing, search technology • Science Technology & Medical division of Reed Elsevier Elsevier Customers in >180 countries (1/3 North America, 1/3 Europe, 1/3 RoW) Serving >30 million scientists, students, health and information professionals 3 General Context • Every day Elsevier records millions of data points on document downloads (or views) on about 12 million scientific publications • This represents extremely valuable information about the involved scientific community(ies)
    [Show full text]